Viatris VTRS
NASDAQ VTRS
$16.50 -0.11 (-0.66%)
As of: Sep 9, 2026 · 3:59 PM EDT

Viatris (VTRS) Finished Goods (2019 - 2026)

Viatris (VTRS) posted Finished Goods of $2.0 billion for Q2 2026, down 1.57% on a QoQ basis from $2.0 billion in Q1 2026, and down 8.45% year-over-year from $2.2 billion in Q2 2025.

Analysis

Viatris (VTRS) Finished Goods (2019 - 2026) Analysis & Trends

Viatris has reported Finished Goods for 8 years, with the latest figure at $2.0 billion in Q2 2026.

  • On a quarterly basis, Finished Goods fell 8.45% year-over-year to $2.0 billion in Q2 2026; TTM through Jun 2026 was $2.0 billion, a 8.45% decrease from a year earlier, with the FY2025 full-year figure at $2.1 billion, up 5.26% from the prior year.
  • Finished Goods was $2.0 billion for Q2 2026 at Viatris, down from $2.0 billion in the prior quarter.
  • The five-year high for Finished Goods was $2.3 billion in Q1 2023, with the low at $1.8 billion in Q3 2022.
  • Average Finished Goods over 5 years is $2.1 billion, with a median of $2.1 billion recorded in 2025.
  • The sharpest annual moves came in 2022 and 2024: Finished Goods retreated 22.53% in 2022, then grew 18.19% in 2024.
  • Over 5 years, Finished Goods stood at $2.2 billion in 2022, then retreated by 2.59% to $2.1 billion in 2023, then fell by 7.26% to $2.0 billion in 2024, then grew by 5.26% to $2.1 billion in 2025, then declined by 4.06% to $2.0 billion in 2026.
  • The last three Finished Goods figures came in at $2.0 billion (Q2 2026), $2.0 billion (Q1 2026), and $2.1 billion (Q4 2025), per Business Quant data.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Teva Pharmaceutical Industries 42.84 Bn 39.19 Bn 2.15 Bn
2 Viatris 19.13 Bn 18.24 Bn 1.46 Bn
3 Dr Reddys Laboratories 9.91 Bn 9.74 Bn 396.53 Mn
4 Amneal Pharmaceuticals 5.51 Bn 5.38 Bn 334.51 Mn
5 Bausch Health Companies 2.30 Bn 464.50 Mn 2.10 Bn
6 Alvotech 1.50 Bn 1.36 Bn 2.56 Mn
7 Ani Pharmaceuticals 1.49 Bn 1.13 Bn 165.89 Mn
8 Amphastar Pharmaceuticals 1.00 Bn 714.13 Mn 93.47 Mn
9 Fennec Pharmaceuticals 402.10 Mn 360.85 Mn 17.15 Mn
10 RedHill Biopharma 178.35 Mn 178.35 Mn -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 2.00 Bn
Mar 31, 2026 2.03 Bn
Dec 31, 2025 2.09 Bn
Sep 30, 2025 2.08 Bn
Jun 30, 2025 2.19 Bn
Mar 31, 2025 2.16 Bn
Dec 31, 2024 1.98 Bn
Sep 30, 2024 2.24 Bn
Jun 30, 2024 2.12 Bn
Mar 31, 2024 2.04 Bn
Dec 31, 2023 2.14 Bn
Sep 30, 2023 1.90 Bn
Jun 30, 2023 2.09 Bn
Mar 31, 2023 2.30 Bn
Dec 31, 2022 2.19 Bn
Sep 30, 2022 1.77 Bn
Jun 30, 2022 1.99 Bn
Mar 31, 2022 2.16 Bn
Dec 31, 2021 2.06 Bn
Sep 30, 2021 2.29 Bn